![Scott Hirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Hirsch
Chief Executive Officer at
Solta Medical Corp.
Profile
Scott Andrew Hirsch is currently Chief Executive Officer at Solta Medical Corp.
since 2021, Chief Executive Officer at Endo Pharmaceuticals, Inc. since 2024, and Director at Solius Labs, Inc. since 2023.
Former roles include Chief Executive Officer at Solta Medical, Inc., Chief Executive Officer & Director at Endo LP from 2024 to 2025, Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2006 to 2009, Analyst at Credit Suisse Securities (USA) LLC (Broker) in 2005, Vice President at Plural Investments LLC from 2011 to 2012, Analyst at Surveyor Capital Ltd. from 2012 to 2014, and Senior VP-Business Strategy & Communications at Bausch Health Cos., Inc. from 2016 to 2017.
Education includes an MBA degree conferred in 2006 from the University of Pennsylvania, undergraduate and graduate studies at the University of Pennsylvania, and undergraduate studies at Rhode Island School of Design.
Scott Hirsch active positions
| Companies | Position | Start |
|---|---|---|
Solta Medical Corp.
 Solta Medical Corp. Medical SpecialtiesHealth Technology Develops skin care technology products | Chief Executive Officer | 2021-08-31 |
Solius
 Solius Medical/Nursing ServicesHealth Services Provides light therapy services | Director/Board Member | 2023-02-21 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Chief Executive Officer | 2024-07-31 |
Former positions of Scott Hirsch
| Companies | Position | End |
|---|---|---|
| ENDO, INC. | Chief Executive Officer | 2025-07-28 |
| BAUSCH HEALTH COMPANIES INC. | Public Communications Contact | - |
Plural Investments LLC
 Plural Investments LLC Investment ManagersFinance Plural Investments manages a multi-strategy hedge fund. The firm tends to invest in the stocks of companies in the process industries, producer manufacturing and healthcare services sectors. Plural Investments invests across all market-caps, with emphasis on the stocks of mid-cap and large-cap companies. Most of their investments are in US companies, but they also invest in Europe and Asia. Plural Investments maintains a high turnover rate | Analyst-Equity | 2010-06-09 |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2009-12-30 |
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2005-12-30 |
Training of Scott Hirsch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Rhode Island School of Design
 Rhode Island School of Design Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solta Medical, Inc.
 Solta Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes aesthetics technologies for skin tightening | Health Technology |
Plural Investments LLC
Plural Investments LLC Investment ManagersFinance Plural Investments manages a multi-strategy hedge fund. The firm tends to invest in the stocks of companies in the process industries, producer manufacturing and healthcare services sectors. Plural Investments invests across all market-caps, with emphasis on the stocks of mid-cap and large-cap companies. Most of their investments are in US companies, but they also invest in Europe and Asia. Plural Investments maintains a high turnover rate | Finance |
Endo, Inc.
 Endo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures branded and generic pharmaceuticals & sterile injectables | Health Technology |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Miscellaneous |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Solius
Solius Medical/Nursing ServicesHealth Services Provides light therapy services | Health Services |
Solta Medical Corp.
Solta Medical Corp. Medical SpecialtiesHealth Technology Develops skin care technology products | Health Technology |
- Stock Market
- Insiders
- Scott Hirsch
